SIBN SI-BONE Inc
Price (delayed)
$14.36
Market cap
$609.63M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.75
Enterprise value
$612.16M
SI-BONE is a medical device company that pioneered minimally invasive surgery of the SI joint with the iFuse Implant System. Studies have shown that the SI joint can be a
Highlights
The EPS rose by 34% YoY and by 18% QoQ
SI-BONE's net income has increased by 29% YoY and by 17% QoQ
SI-BONE's quick ratio has decreased by 18% YoY and by 8% QoQ
Key stats
What are the main financial stats of SIBN
Market
Valuations
Earnings
Shares outstanding
42.45M
Market cap
$609.63M
Enterprise value
$612.16M
Price to earnings (P/E)
N/A
Price to book (P/B)
3.61
Price to sales (P/S)
3.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.66
Revenue
$167.18M
Gross profit
$132.12M
Operating income
-$35.25M
Net income
-$30.91M
EBIT
-$27.47M
EBITDA
-$23.09M
Free cash flow
-$22.92M
Per share
Balance sheet
Liquidity
EPS
-$0.75
EPS diluted
-$0.75
Free cash flow per share
-$0.55
Book value per share
$3.98
Revenue per share
$4.03
TBVPS
$5.56
Total assets
$230.44M
Total liabilities
$63.47M
Debt
$37.48M
Equity
$166.96M
Working capital
$180.65M
Debt to equity
0.22
Current ratio
7.66
Quick ratio
6.54
Net debt/EBITDA
-0.11
Margins
Efficiency
Dividend
EBITDA margin
-13.8%
Gross margin
79%
Net margin
-18.5%
Operating margin
-21.1%
Return on assets
-13.7%
Return on equity
-18.7%
Return on invested capital
-13.1%
Return on capital employed
-13.5%
Return on sales
-16.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SIBN stock price
How has the SI-BONE stock price performed over time
Intraday
2.28%
1 week
2.32%
1 month
-20.75%
1 year
-7.77%
YTD
2.43%
QTD
2.35%
Financial performance
How have SI-BONE's revenue and profit performed over time
Revenue
$167.18M
Gross profit
$132.12M
Operating income
-$35.25M
Net income
-$30.91M
Gross margin
79%
Net margin
-18.5%
SI-BONE's net margin has increased by 41% YoY and by 22% from the previous quarter
The company's operating margin rose by 38% YoY and by 22% QoQ
SI-BONE's net income has increased by 29% YoY and by 17% QoQ
The operating income is up by 25% year-on-year and by 17% since the previous quarter
Growth
What is SI-BONE's growth rate over time
Valuation
What is SI-BONE stock price valuation
P/E
N/A
P/B
3.61
P/S
3.56
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.66
The EPS rose by 34% YoY and by 18% QoQ
SIBN's P/B is 32% below its 5-year quarterly average of 5.2
The P/S is 51% less than the 5-year quarterly average of 7.1 and 8% less than the last 4 quarters average of 3.8
The company's revenue rose by 20% YoY and by 6% QoQ
Efficiency
How efficient is SI-BONE business performance
The ROS rose by 43% YoY and by 24% QoQ
The ROIC has grown by 42% YoY and by 18% from the previous quarter
The ROE has grown by 34% YoY and by 17% from the previous quarter
SI-BONE's ROA has increased by 33% YoY and by 17% from the previous quarter
Dividends
What is SIBN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SIBN.
Financial health
How did SI-BONE financials performed over time
SI-BONE's quick ratio has decreased by 18% YoY and by 8% QoQ
The current ratio has declined by 15% year-on-year and by 7% since the previous quarter
SI-BONE's debt is 78% less than its equity
SI-BONE's debt has decreased by 3.9% YoY and by 2.7% from the previous quarter
The debt to equity has declined by 4.3% since the previous quarter and by 4.3% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.